Wealth Enhancement Advisory Services
BCRX icon

Wealth Enhancement Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$338K Buy
2025
Q1 		$283K Buy
2024
Q4 		$133K Buy
2024
Q3 		$132K Buy
2024
Q2 		$74.2K Buy
2024
Q1 		$57.2K Buy
2023
Q4 		– Sell
2023
Q3 		$88.9K Buy